Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Beta Bionics, Inc. Common Stock, $0.0001 par value per share (BBNX).
- Disclosed ownership: 3.7%.
- Date of event: 31 Mar 2025.
PERCEPTIVE ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Beta Bionics, Inc. Common Stock, $0.0001 par value per share (BBNX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- BBNX
- Shares outstanding
- 43,304,565 shares
- Disclosed Ownership
- 1,593,608 shares
- Ownership
- 3.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Aug 2025, 11:36:20 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 3.7% ownership in Beta Bionics, Inc. Common Stock, $0.0001 par value per share (BBNX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Aug 2025, 11:36.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3.7% | 1,593,608 | 0 | 1,593,608 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 3.7% | 1,593,608 | 0 | 1,593,608 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 3.7% | 1,593,608 | 0 | 1,593,608 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |